ALC vs EWTX
Alcon Inc vs Edgewise Therapeutics, Inc. — AI-powered side-by-side comparison
VS
EWTX
Edgewise Therapeutics, Inc.
61
Buy
| Metric | ALC | EWTX |
|---|
| AI Score |
68
|
61
|
| Price |
$75.39
|
$44.30
|
| P/E Ratio |
45.39×
|
-23.95×
|
| ROE |
4.4%
|
-32.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
0.0%
|
| Debt / Equity |
0.24×
|
0.01×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
61.0
|
| Beta |
0.703
|
0.275
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus EWTX.
ALC leads by 7 points.
ALC scores 68/100 (Buy) versus EWTX at 61/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
EWTX Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Price-to-book of 5.0x prices in significant intangible value — Value
- ROE of only -39.0% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 23.8% signals elevated volatility — Risk